Company: CI
Filing Date: 2025-07-31
Form Type: 10-Q
Source: 0001739940-25-000028
Chunk: 37

Company: Cigna Group
Filing Date: 2025-07-31
Form: 10-Q
Item: Part II, Item 4
Chunk 37
---
loss) on sale of businesses— — N/M41 (19)N/MNet investment gains (losses)52 (48)N/M50 (1,884)N/MIncome before income taxes2,021 1,989 2 3,669 2,068 77 Total income taxes389 360 8 628 651 (4)Net income1,632 1,629 — 3,041 1,417 115 Less: Net income attributable to noncontrolling interests100 81 23 186 146 27 Shareholders' net income$1,532 $1,548 (1)%$2,855 $1,271 125 %Consolidated effective tax rate19.2 %18.1 %110 bps17.1 %31.5 %(1,440)bpsMedical customers (in thousands)18,046 19,043 (5)%

34

Reconciliation of Shareholders' Net Income (GAAP) to Adjusted Income from OperationsThree Months Ended June 30,Six Months Ended June 30,2025202420252024(In millions)Pre-taxAfter-taxPre-taxAfter-taxPre-taxAfter-taxPre-taxAfter-taxShareholders' net income$1,532 $1,548 $2,855 $1,271 Adjustments to reconcile to adjusted income from operationsNet investment (gains) losses (1)$(96)(103)$(5)(20)$(144)(151)$1,823 1,807 Amortization of acquired intangible assets422 330 420 317 844 666 843 639 Special itemsStrategic optimization program129 98 — — 344 261 — — Integration and transaction-related costs74 56 63 47 290 220 100 76 (Gain) loss on sale of businesses — — — — (41)(115)19 (43)Deferred tax expenses, net (2)— 17 — 17 — 34 — 34 Total special items$203 171 $63 64 $593 400 $119 67 Adjusted income from operations$1,930 $1,909 $3,770 $3,784 

(1)Includes Net investment gains/losses as presented in